Basel Medical Group Ltd Ordinary Shares
BMGL
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $7.6M
$4.83
▲ +1.05%
P/E
—
Mkt Cap
$7.6M
52-Wk Range
$4.17–$25.80
52-Week Range
$4.17 - $25.80
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 79.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Integrated healthcare platform offering end-to-end medical solutions
- Strong positioning in Singapore's developed healthcare market
- Diversified revenue streams across multiple healthcare segments
- Early-mover advantage as a newly incorporated healthcare provider with fresh operational frameworks
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
No forward estimates available
Rising healthcare spending in Southeast Asia and aging demographic trends
Value
Valuation data unavailable
Momentum
Falling
-32.4% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying BMGL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Earnings recap unavailable for this period.
Reported EPS · last 4Q
No quarterly earnings data on file.
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BMGL stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related